| Name | Title | Contact Details |
|---|---|---|
Patty Levy |
Director, People and Culture Partner | Profile |
Lucy Glazebrook |
Associate Director, Financial Reporting | Profile |
Tiffany Hollinger |
Associate Director, R&D Program Management & Operations | Profile |
Gloria Cosgrove |
Senior Director, Donor/Clinical/R&D QA | Profile |
Kelley Whitman |
Executive Director, HR Business Partner | Profile |
Sonoma Biotherapeutics is inventing the future of living therapies for autoimmune disease — safe, effective treatments as unique as each individual patient. Regulatory T cell therapies that harness a patient`s own immune cells, powerful next generation gene editing techniques and advanced manufacturing and quality assurance processes. Sonoma`s mission is to create a best-in-class regulatory T cell therapy that delivers long-lasting, highly efficacious treatments leading to cures across a spectrum of autoimmune and degenerative diseases.
FerGene is a new gene therapy company dedicated to creating and delivering innovative solutions to urologists and those affected by non-muscle invasive bladder cancer (NMIBC).
Nutra-C is a Laurel, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
InMed Diagnostics is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HiFiBiO SAS commercializes proprietary single cell technologies for applications in drug and biomarker discovery and development.